ORYZON to give updates on corporate progress in June 06/06/2022 Corporate Oryzon Genomics, S.A, announced today that its management will give an update on corporate progress at several... Partners - Oryzon Genomics
BIOLAN receives a new recognition for its innovate analytical digitalization solution at F... 02/06/2022 Agrifood Corporate BIOLAN was a finalist in the Agrobank Award, which recognizes the most innovative digitalisation solution, for its new... Partners - Biolan
Celtarys Research will present its technology for optimizing drug discovery at the XX Nati... 31/05/2022 Corporate With the title of "From early discovery to translational medicinal chemistry" the next meeting of the Spanish Society of... Partners - Celtarys Research
BCN HEALTH publishes a study evaluating the hospital incidence and medical costs of chroni... 30/05/2022 Healthcare Corporate BCN HEALTH has published the study ‘Chronic inflammatory demyelinating polyneuropathy in Spain: a retrospective analysis... Partners - BCN Health
El grupo Zendal adquiere el 46% de Maymó 11/05/2022 Corporate Con esta operación, la biotecnológica gallega se convierte así en nuevo socio estratégico del grupo Maymó Partners - Zendal
Nuage Therapeutics appoints biotech entrepreneur and executive Judit Anido as CEO 10/05/2022 Healthcare Access to innovation Corporate Judit Anido joins Nuage Therapeutics as co-founder and CEO and becomes member of the Board of Directors Partners - Asabys Partners
Integra Therapeutics appoints Mark Bonyhadi as new independent director 03/05/2022 Corporate Dr Mark Bonyhadi is an experienced executive with over 30 years in the biopharmaceutical industry Partners - Integra Therapeutics S.L.
ORYZON to give updates on corporate progress in May 29/04/2022 Access to innovation Corporate Oryzon Genomics, S.A., announced today that its management will give an update on corporate progress at several... Partners - Oryzon Genomics
GENESIS Biomed and FI Group create GENESIS Tech Transfer Boost, a new investment vehicle t... 29/04/2022 Corporate GENESIS Biomed and FI Group create GENESIS Tech Transfer Boost, a new investment vehicle that will invest in early stage... Partners - GENESIS Biomed
Sanifit, Ysios Capital, Splice Bio and MOA foodtech recognised at first AseBio – PwC Award... 29/04/2022 The ceremony to award these 6 prizes to Spanish biotechnology took place at AseBio Investor Day 2022, which brought... AseBio
